

Is Estarylla 28 Day in shortage in 2026? Get the latest update on availability, cost, and what you can do if your pharmacy is out of stock.
If you've been told your pharmacy can't fill your Estarylla 28 Day prescription, you're probably wondering: is there an actual shortage? And how long will it last? Here's what we know as of 2026.
As of early 2026, Estarylla 28 Day is not listed as an active shortage on the FDA's drug shortage database. However, that doesn't mean it's easy to find at every pharmacy. Many patients report difficulty filling their Estarylla prescription at their usual pharmacy, even when there's no official national shortage.
The reality is that oral contraceptive availability has been unpredictable since 2022. Spot shortages — where specific pharmacies or regions run out temporarily — have become common for many birth control pills, including Estarylla and similar Norgestimate/Ethinyl Estradiol products.
Several factors contribute to the difficulty patients experience when trying to fill their Estarylla prescriptions:
The pharmaceutical supply chain has been under strain for years. Manufacturing delays, raw material shortages, and transportation disruptions can all cause temporary gaps in supply. Even a brief manufacturing pause can lead to weeks of limited availability at the pharmacy level.
Pharmaceutical distributors allocate medications to pharmacies based on historical ordering patterns. If a pharmacy hasn't regularly stocked Estarylla, it may not receive adequate supply — even when the manufacturer has product available. This means some pharmacies have it while others a few miles away don't.
Each year, insurance companies update their formularies — the list of preferred drugs they cover. When a plan shifts its preferred Norgestimate/Ethinyl Estradiol product, demand can spike for one brand and drop for another. These shifts create uneven demand that the supply chain can't always absorb smoothly.
Estarylla competes with Sprintec, Previfem, Mono-Linyah, Mili, and Femynor — all branded generics of the same drug. When any one of these experiences a supply issue, patients are redirected to the remaining brands, which can overwhelm their supply in turn.
Cost shouldn't be a barrier to getting your birth control. Here's the current pricing landscape:
For a complete guide to saving money, read our post on how to save money on Estarylla 28 Day.
While no new Norgestimate/Ethinyl Estradiol products have launched recently, the market continues to have multiple branded generic options. The key options remain:
Additionally, telehealth services now make it easier than ever to get a new prescription or switch medications. Services like Nurx, SimpleHealth, and The Pill Club can prescribe and ship oral contraceptives directly to your home — which can be a great option if local pharmacies don't have what you need.
For a full comparison, see our guide on alternatives to Estarylla 28 Day.
If you're currently looking for Estarylla, here's a step-by-step plan:
For more detailed tips, read our full guide on how to find Estarylla 28 Day in stock near you.
While Estarylla 28 Day isn't in an official FDA shortage in 2026, real-world availability remains spotty for many patients. Supply chain disruptions, distributor allocation practices, and insurance formulary changes all play a role. The good news is that multiple equivalent products exist, discount cards can bring costs down significantly, and tools like Medfinder make it easier to find what you need.
Don't go without your birth control. Use the resources available to you, talk to your pharmacist and prescriber, and know that you have options.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.